Cargando…

Retention rates of antiepileptic drugs in glioma patients: the most appropriate outcome

Detalles Bibliográficos
Autores principales:	van der Meer, Pim B, Dirven, Linda, Fiocco, Marta, Taphoorn, Martin JB, Koekkoek, Johan AF
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341164/ https://www.ncbi.nlm.nih.gov/pubmed/32602750 http://dx.doi.org/10.2217/cns-2020-0009

Ejemplares similares

Efficacy of antiepileptic drugs in glioma patients with epilepsy: a systematic review
por: de Bruin, Marjolein E, et al.
Publicado: (2021)

The effectiveness of antiepileptic drug treatment in glioma patients: lamotrigine versus lacosamide
por: van Opijnen, Mark P., et al.
Publicado: (2021)

First‐line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid
por: van der Meer, Pim B., et al.
Publicado: (2021)

Effect of antiepileptic drugs in glioma patients on self-reported depression, anxiety, and cognitive complaints
por: van der Meer, Pim B., et al.
Publicado: (2021)

Effectiveness of Antiseizure Medication Duotherapies in Patients With Glioma: A Multicenter Observational Cohort Study
por: van der Meer, Pim B., et al.
Publicado: (2022)

Effectiveness of Antiseizure Medication Triple Therapy in Patients With Glioma With Refractory Epilepsy: An Observational Cohort Study
por: van der Meer, Pim B., et al.
Publicado: (2023)

Impact of timing of antiseizure medication withdrawal on seizure recurrence in glioma patients: a retrospective observational study
por: van der Meer, Pim B., et al.
Publicado: (2023)

Prescription preferences of antiepileptic drugs in brain tumor patients: An international survey among EANO members
por: van der Meer, Pim B, et al.
Publicado: (2021)

Prediagnostic presentations of glioma in primary care: a case–control study
por: Peeters, Marthe CM, et al.
Publicado: (2019)

First‐line levetiracetam versus enzyme‐inducing antiseizure medication in glioma patients with epilepsy
por: van der Meer, Pim B., et al.
Publicado: (2022)

Management of epilepsy in brain tumor patients
por: van der Meer, Pim B., et al.
Publicado: (2022)

The Impact of the Timing of Health-Related Quality of Life Assessments on the Actual Results in Glioma Patients: A Randomized Prospective Study
por: Peeters, Marthe C.M., et al.
Publicado: (2020)

Antiepileptic drug treatment in the end-of-life phase of glioma patients: a feasibility study
por: Koekkoek, Johan A. F., et al.
Publicado: (2015)

Research Objectives, Statistical Analyses and Interpretation of Health-Related Quality of Life Data in Glioma Research: A Systematic Review
por: Coomans, Marijke B., et al.
Publicado: (2020)

Withdrawal of antiepileptic drugs in glioma patients after long-term seizure freedom: design of a prospective observational study
por: Koekkoek, Johan A F, et al.
Publicado: (2014)

Depression and anxiety in glioma patients
por: van der Meer, Pim B, et al.
Publicado: (2023)

Withdrawal of antiepileptic drugs in patients with low grade and anaplastic glioma after long-term seizure freedom: a prospective observational study
por: Kerkhof, M., et al.
Publicado: (2019)

Health-related quality of life in high-grade glioma patients
por: Dirven, Linda, et al.
Publicado: (2014)

Is the EORTC QLQ‐C30 emotional functioning scale appropriate as an initial screening measure to identify brain tumour patients who may possibly have a mood disorder?
por: Oort, Quirien, et al.
Publicado: (2022)

Seizure reduction is a prognostic marker in low-grade glioma patients treated with temozolomide
por: Koekkoek, Johan A. F., et al.
Publicado: (2015)

Step Therapy Is Not Appropriate for Antiepileptic Drugs
por: Welty, Timothy E., et al.
Publicado: (2006)

Evaluating the lack of impact of the e-health application Oncokompas on outcomes in incurably ill cancer patients
por: Dirven, Linda, et al.
Publicado: (2022)

Advance Care Planning in Glioblastoma Patients
por: Fritz, Lara, et al.
Publicado: (2016)

How to choose the most appropriate cognitive test to evaluate cognitive complaints in primary care
por: Janssen, Jolien, et al.
Publicado: (2017)

Advance care planning in glioblastoma patients: development of a disease-specific ACP program
por: Fritz, Lara, et al.
Publicado: (2019)

Long-Term Disease Burden and Survivorship Issues After Surgery and Radiotherapy of Intracranial Meningioma Patients
por: Zamanipoor Najafabadi, Amir H, et al.
Publicado: (2020)

The long-term caregiver burden in World Health Organization grade I and II meningioma: It is not just the patient
por: Zamanipoor Najafabadi, Amir H, et al.
Publicado: (2020)

Determinants and predictors for the long-term disease burden of intracranial meningioma patients
por: Zamanipoor Najafabadi, Amir H., et al.
Publicado: (2020)

Long-Term Disease Burden and Survivorship Issues After Surgery and Radiotherapy of Intracranial Meningioma Patients
por: Zamanipoor Najafabadi, Amir H, et al.
Publicado: (2021)

Antiepileptic Drugs
por: Prichard, J. W.
Publicado: (1974)

The Role of 5-ALA in Low-Grade Gliomas and the Influence of Antiepileptic Drugs on Intraoperative Fluorescence
por: Goryaynov, Sergey A., et al.
Publicado: (2019)

The impact of current treatment modalities on the outcomes of patients with melanoma brain metastases: A systematic review
por: van Opijnen, Mark P., et al.
Publicado: (2019)

Antiepileptic drugs and suicidality
por: Britton, Jeffery W, et al.
Publicado: (2010)

Antiepileptic drugs and breastfeeding
por: Davanzo, Riccardo, et al.
Publicado: (2013)

Teratogenicity of Antiepileptic Drugs
por: Güveli, Betül Tekin, et al.
Publicado: (2017)

A Systematic Comparison Identifies an ATP-Based Viability Assay as Most Suitable Read-Out for Drug Screening in Glioma Stem-Like Cells
por: Kleijn, A., et al.
Publicado: (2016)

Individual changes in neurocognitive functioning and health-related quality of life in patients with brain oligometastases treated with stereotactic radiotherapy
por: van der Meer, Pim B., et al.
Publicado: (2018)

Neurocognitive impairment and patient–proxy agreement on health-related quality of life evaluations in recurrent high-grade glioma patients
por: Caramanna, Ivan, et al.
Publicado: (2022)

Selecting the most appropriate treatment for each patient
por: Beutler, Larry E., et al.
Publicado: (2016)

Antiepileptic drugs and bone metabolism
por: Valsamis, Helen A, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_lsceute5l2hte04eqfu2h8she4